NasdaqGM - Nasdaq Real Time Price • USD
Wave Life Sciences Ltd. (WVE)
As of 10:24 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -0.21 | -0.24 | -1.01 | -1.07 |
| Low Estimate | -0.34 | -0.3 | -1.32 | -1.52 |
| High Estimate | -0.04 | -0.19 | -0.63 | -0.87 |
| Year Ago EPS | -0.27 | -0.2 | -0.54 | -1.01 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | 22.95M | 19.61M | 76.38M | 52.83M |
| Low Estimate | 10M | 10M | 40M | 6M |
| High Estimate | 39.67M | 25M | 100M | 98.36M |
| Year Ago Sales | 32.33M | 7.94M | 113.31M | 76.38M |
| Sales Growth (year/est) | -29.00% | 147.00% | -32.60% | -30.80% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.04 | -0.33 | -0.18 | -0.23 |
| EPS Actual | -0.27 | -0.2 | 0.07 | -0.15 |
| Difference | -0.23 | 0.13 | 0.25 | 0.08 |
| Surprise % | -575.00% | 39.40% | 138.90% | 34.80% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.21 | -0.24 | -1.01 | -1.07 |
| 7 Days Ago | -0.21 | -0.24 | -1.01 | -1.07 |
| 30 Days Ago | -0.21 | -0.24 | -1.01 | -1.07 |
| 60 Days Ago | -0.2 | -0.21 | -0.95 | -1.07 |
| 90 Days Ago | -0.2 | -0.21 | -0.95 | -1.07 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | WVE | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 22.20% | -- | -- | 1.50% |
| Next Qtr. | -20.00% | -- | -- | 11.40% |
| Current Year | -87.00% | -- | -- | 5.20% |
| Next Year | -5.90% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Truist Securities: Buy to Buy | 4/1/2024 |
| Maintains | Mizuho: Buy to Buy | 3/12/2024 |
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 3/7/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/7/2024 |
| Upgrade | Leerink Partners: Market Perform to Outperform | 12/19/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/4/2023 |
Related Tickers
PRQR ProQR Therapeutics N.V.
1.9500
-2.99%
ARWR Arrowhead Pharmaceuticals, Inc.
22.15
-4.89%
RNA Avidity Biosciences, Inc.
23.85
-4.94%
KRRO Korro Bio, Inc.
56.20
-10.78%
IONS Ionis Pharmaceuticals, Inc.
42.10
-0.82%
VRDN Viridian Therapeutics, Inc.
12.55
-3.72%
SNDX Syndax Pharmaceuticals, Inc.
20.53
-1.25%
TVTX Travere Therapeutics, Inc.
5.21
-4.40%
STOK Stoke Therapeutics, Inc.
11.46
-1.73%
VYGR Voyager Therapeutics, Inc.
7.34
-3.10%